| Domain | Rank | Visitors | Earning per month | Valuation |
| astrazeneca-us.com | 760445 | 4,123 | 575$ | 17250$ |
| azcollaboration.sharepoint.com | 150475 | 1,606 | 508$ | 15240$ |
| astrazeneca.net | 265836 | 5,141 | 1,195$ | 35850$ |
| gsk.com | 22999 | 17,183 | 3,835$ | 115050$ |
| novartis.com | 73511 | 16,616 | 2,936$ | 88080$ |
| azandmeapp.com | 1822615 | 338 | 94$ | 2820$ |
| azpicentral.com | 1369805 | 1,419 | 132$ | 3960$ |
| astrazeneca.ca | 1229231 | 3,500 | 326$ | 9780$ |
| Moz Backlinks Count | 4891 |
| Moz Page Rank | 5 |
| Domain Authority (DA) | 69.0 |
| Page Authority (PA) | 51.0 |
| Country | Rank | Pct |
|---|
| Country Name | China |
| Country Rank | 16361
8987
|
| Daily unique visits | 4,803 |
| Daily Page Views | 25,458 |
| Income Per Day | 2,368 USD |
| Astrazeneca.com valuation | 71040 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | Precision medicine - targeting the right medicine to the right patient at the right time |
| 2 | Our Sustainability ambition |
| No | Text |
| 1 | What science can do |
| 2 | "Each patient’s breast cancer is unique to them and requires personalised treatment. Thankfully, scientific advances have expanded our ability to identify and target specific subtypes of breast cancer in new ways with the aim of helping more patients." |
| 3 | Discover our dedication to being a great place to work |
| 4 | 183 |
| 5 | Our Cambridge site (UK) is one of AstraZeneca's three global science centres |
| 6 | Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen |
| 7 | Lynparza recommended for approval in the EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer |
| 8 | AstraZeneca Websites |
| Social | Count |
| Facebook Likes | 2096 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |